A promising approach for preventing cognitive and behavioral impairment following ischemia AURORA, Colo., Sept. 18, 2024 /PRNewswire-PRWeb/ — Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
COMMERCE CITY, Colo., Aug. 28, 2023 /PRNewswire/ — Starting this week, the National Alliance for Hispanic Health, Vuela for Health, Delta Research Education Foundation, Colorado Alliance for Health Equity and Practice, Asian Health Coalition, and […]
Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known […]
Governor Polis Signed House Bill 1164 Into Law, Making Colorado the 20th State to Provide Free Period Products DENVER, June 5, 2024 /PRNewswire/ — Today, Governor Jared Polis signed the historic House Bill 1164, “Free […]
Copyright © 2026 Biotech Networks
